Bioramics

About Bioramics Bioramics is a biotech de-risking and development platform built to solve one of the biggest challenges in translational science: transforming university-born discoveries into acquisition-ready assets. While most biotech innovations stall in the “Valley of Death,” Bioramics delivers a structured, expert-led model that advances them across it—with speed, precision, and regulatory confidence. What We Do We take in early-stage discoveries—typically from university labs—and place each one into its own dedicated Target LLC. These assets are then managed through our operational arm, SciRegenix, a team of nationally recognized scientists, regulatory experts, and commercialization professionals. Our execution is milestone-driven, capital-efficient, and fully aligned with investor, university, and acquirer goals. Why It Matters Over 90% of innovations never reach the marketplace—not because they lack potential, but because they lack execution. Bioramics exists to change that. With our platform in place, universities gain ROI on research, inventors maintain academic focus, funders see visible progress, and buyers receive clean, de-risked, ready-to-integrate solutions. Who We Serve - Universities & Tech Transfer Offices - Faculty Inventors & Researchers - Philanthropic Donors & Sponsors - Venture Investors & Strategic Partners - Big Pharma & Acquirers Our Mission To bridge the gap between scientific discovery and global impact by turning breakthrough research into life-changing biotech solutions. Now Seeking Partners We welcome collaboration with research institutions, accelerators, philanthropic sponsors, and potential acquirers who share our commitment to bringing the best of science to the world.